4D pharma plc (DDDD.L) (LON:DDDD)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $126.00, but opened at $122.00. 4D pharma plc (DDDD.L) shares last traded at $126.50, with a volume of 1,172,754 shares changing hands.
The business’s fifty day simple moving average is GBX 108.58 and its 200-day simple moving average is GBX 98.08. The company has a current ratio of 3.16, a quick ratio of 3.13 and a debt-to-equity ratio of 3.50. The firm has a market cap of £169.08 million and a P/E ratio of -4.11.
4D pharma plc (DDDD.L) Company Profile (LON:DDDD)
4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company's development programs include Blautix for irritable bowel syndrome and Thetanix for paediatric crohn's disease. It also develops immuno-oncology products comprising MRx0518, MRx0573, and MRx1299 for solid tumors, and MRx0518 for pancreatic cancer; respiratory products, such as MRx-4DP0004 for asthma and COVID-19; central nervous system products, including MRx0005 and MRx0029 for neurodegeneration; and platform products comprising vaccines and autoimmune.
See Also: What is a support level?
Receive News & Ratings for 4D pharma plc (DDDD.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4D pharma plc (DDDD.L) and related companies with MarketBeat.com's FREE daily email newsletter.